Shapiro failed to come through on a similar pledge to support transit during last year’s budget negotiations. The governor, ...

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

Response Pharmaceuticals, Inc., a clinical-stage company focused on weight management and metabolic health in high-risk populations, today announced the early completion of enrollment in a Phase 2 ...

Eli Lilly achieved the largest market capitalisation growth of 32.4% to $733bn in 2024, driven by strong demand for Mounjaro ...

Allen surrendered four goals on 27 shots in Sunday's 4-3 loss to the Sabres. New Jersey almost pulled off the comeback Sunday, but Buffalo's three-goal first period was too much to surmount. Allen has ...

The Iowa women’s basketball program in recent games has seemingly regained its footing, emerging from a dismal five-game ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

Crucially, the top-line reduction differed very little from the weight loss seen with Eli Lilly's combined GIP/GLP-1 agonist Zepbound (tirzepatide) at 72 weeks in the SURMOUNT-1 study, which was a ...

Perrysburg, Ohio, Feb. 05, 2025 (GLOBE NEWSWIRE) -- ...

The historical novelist died suddenly of a stroke in September, 2022, aged 70, having amassed a fortune of £4,677,327, later ...